GlassScriptPhysician profile
Kerry M Sims
NPI 1457407132
$423.68
in general payments reported to CMS, 2019-2025
13 companies · $68.38 in 2025
The $68.38 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.88 · 2022: $36.23 · 2023: $209 · 2024: $97.53 · 2025: $68.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $132.69 | 2023 | Veozah |
| Dexcom, INC. | $50.89 | 2024-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $44.88 | 2023-2024 | Ligasure |
| Optumhealth Care Solutions, LLC | $33.30 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mylan Pharmaceuticals INC. | $26.84 | 2021-2022 | |
| Hydrofera LLC | $24.70 | 2025 | Hydrofera Blue |
| Agile Therapeutics, INC. | $22.27 | 2022 | |
| Solventum Corporation | $20.38 | 2025 | Prevena |
| Aspira Women'S Health INC | $19.16 | 2023 | Ova1 |
| Abbott Laboratories | $17.46 | 2023 | Freestyle Libre 3 |
| Exeltis, USA INC. | $14.21 | 2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $13.37 | 2023 | |
| Organon LLC | $3.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.